New rival for Ozempic and Mounjaro

American researchers have developed an experimental compound called "TOFA" that works to reduce fat, improve blood sugar levels, and alleviate fatty liver, all without significant loss of muscle mass. It achieves this by increasing energy expenditure through helping cells burn fat more effectively. Unlike weight loss drugs that primarily suppress appetite, "TOFA" promotes fat burning and boosts energy consumption by up to 18% in experiments on mice, without changing physical activity levels or raising body temperature. The researchers aim to develop it as a supplement to appetite-suppressing medications, although its trials have so far only been conducted on animals. Human trials are necessary to ensure its safety and effectiveness.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل